to avoid the inhibitory effect of ehdp on bone mineralization , a variety of diphosphonates ( cl2mdp , apd ) and a combination of ehdp with calcitonin have been used in the treatment of paget 's disease .
C0006668
calcitonin
C0029401
paget 's disease